Moderna MRNA Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Moderna’s reported figures.
Based on the most recent quarter.
The official record: Moderna’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Moderna's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Moderna's quick ratio?
- Moderna (MRNA) reported quick ratio of 2.4× in Q1 2026.
- How has Moderna's quick ratio changed year-over-year?
- Moderna's quick ratio decreased by 42.9% year-over-year, from 4.1× to 2.4×.
- What is the long-term trend for Moderna's quick ratio?
- Over 4 years (2021 to 2025), Moderna's quick ratio has grown at a 29.6% compound annual growth rate (CAGR), from 5.4× to 15.1×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.